Methylation Sequencing
Methylation Sequencing provides researchers with a clear way to study DNA methylation across the genome. This method shows where cytosine bases are methylated, helping scientists understand how epigenetic changes control gene expression. In practice, methylation sequencing is widely used in cancer research, developmental biology, and neuroscience to link DNA modifications with changes in cell behavior. Many labs also apply it to aging studies and environmental epigenetics. The workflow supports whole-genome methylation mapping as well as targeted regions, giving flexibility depending on the project. Gentaur offers optimized protocols and reliable reagents so researchers can focus on results rather than technical obstacles.
AMM00304G
Monoclonal Involucrin (Squamous Cell Terminal Differentiation Marker) Antibody - Without BSA and Azide, Clone: SY5
Ask
AMM00305G
Monoclonal Involucrin (Squamous Cell Terminal Differentiation Marker) Antibody - With BSA and Azide, Clone: SPM259
Ask
AMM00942G
Monoclonal Involucrin (Squamous Cell Terminal Differentiation Marker) Antibody, Clone: SY5
Ask
AMM00943G
Monoclonal Involucrin (Squamous Cell Terminal Differentiation Marker) Antibody, Clone: SPM259
Ask
AMM00306G
Monoclonal Involucrin (Squamous Cell Terminal Differentiation Marker) Antibody - Without BSA and Azide, Clone: SPM259
Ask
AMM00946G
Monoclonal Involucrin (Squamous Cell Terminal Differentiation Marker) Antibody - Without BSA and Azide, Clone: IVRN/827
Ask
AMM00944G
Monoclonal Involucrin (Squamous Cell Terminal Differentiation Marker) Antibody, Clone: IVRN/827
Ask
AMM00945G
Monoclonal Involucrin (Squamous Cell Terminal Differentiation Marker) Antibody - With BSA and Azide, Clone: IVRN/827
Ask
AMM00187G
Monoclonal Involucrin (Squamous Cell Terminal Differentiation Marker) Antibody - With BSA and Azide, Clone: SY5
Ask